VANTIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Vantin, and when can generic versions of Vantin launch?
Vantin is a drug marketed by Pharmacia And Upjohn and is included in two NDAs.
The generic ingredient in VANTIN is cefpodoxime proxetil. There are ten drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the cefpodoxime proxetil profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Vantin
A generic version of VANTIN was approved as cefpodoxime proxetil by AUROBINDO PHARMA LTD on June 8th, 2007.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for VANTIN?
- What are the global sales for VANTIN?
- What is Average Wholesale Price for VANTIN?
Summary for VANTIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 51 |
| Clinical Trials: | 2 |
| Patent Applications: | 2,093 |
| DailyMed Link: | VANTIN at DailyMed |
Recent Clinical Trials for VANTIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Washington University School of Medicine | N/A |
| University of Oklahoma | Phase 1 |
US Patents and Regulatory Information for VANTIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmacia And Upjohn | VANTIN | cefpodoxime proxetil | FOR SUSPENSION;ORAL | 050675-001 | Aug 7, 1992 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Pharmacia And Upjohn | VANTIN | cefpodoxime proxetil | TABLET;ORAL | 050674-002 | Aug 7, 1992 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Pharmacia And Upjohn | VANTIN | cefpodoxime proxetil | FOR SUSPENSION;ORAL | 050675-002 | Aug 7, 1992 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Pharmacia And Upjohn | VANTIN | cefpodoxime proxetil | TABLET;ORAL | 050674-001 | Aug 7, 1992 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
